Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A3 | Q9HAS3 | 4/20 | 0.68 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.61 |
| ▸ | TYR | P14679 | 3/20 | 0.59 |
| ▸ | ATM | Q13315 | 1/20 | 0.57 |
| ▸ | SLC5A2 | P31639 | 5/20 | 0.56 |
| ▸ | SLC5A1 | P13866 | 3/20 | 0.55 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3662700 | 1.00 | SLC28A3 (0.68) | SLC28A3HIF1ATYRATMSLC5A2 | |
| SCHEMBL2927767 | 1.00 | SLC28A3 (0.68) | SLC28A3HIF1ATYRATMSLC5A2 | |
| SCHEMBL13324378 | 1.00 | SLC28A3 (0.68) | SLC28A3HIF1ATYRATMSLC5A2 | |
| SCHEMBL1706261 | 0.98 | SLC28A3 (0.69) | SLC28A3HIF1ATYRATMSLC5A2 | |
| SCHEMBL3664789 | 0.98 | SLC28A3 (0.69) | SLC28A3HIF1ATYRATMSLC5A2 | |
| SCHEMBL7181752 | 0.98 | SLC28A3 (0.69) | SLC28A3HIF1ATYRATMSLC5A2 | |
| SCHEMBL2923796 | 0.98 | SLC28A3 (0.69) | SLC28A3HIF1ATYRATMSLC5A2 | |
| SCHEMBL8657750 | 0.98 | SLC28A3 (0.69) | SLC28A3HIF1ATYRATMSLC5A2 | |
| SCHEMBL166162 | 0.98 | SLC28A3 (0.69) | SLC28A3HIF1ATYRATMSLC5A2 | |
| SCHEMBL12610461 | 0.88 | SLC28A3 (0.71) | SLC28A3HIF1ATYRATMSLC5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107446986-A | Culture medium of microorganism and preparation method thereof in a kind of detection blood of human body | 青岛金典生化器材有限公司 | 2017-12-08 | — | — | CN | claimed |
| US-20100297692-A1 | REACTION MEDIUM FOR DETECTING AND/OR IDENTTIFYING STAPHYLOCCOUS AUREUS | BIOMERIEUX (FR) | 2010-11-25 | — | — | US | claimed |
| CN-101874118-A | Detect and/or identify the reaction culture medium of streptococcus aureus | BIOMERIEUX SA | 2010-10-27 | — | — | CN | claimed |
| EP-2225391-A1 | REACTION MEDIUM FOR DETECTING AND/OR IDENTIFYING STAPHYLOCCOCUS AUREUS | Biomérieux (FR) | 2010-09-08 | — | — | EP | claimed |
| US-7709223-B2 | Method for detecting bacteria with chromogenic substrates for β-D-ribofuranosidase | BURTON MICHAEL | 2010-05-04 | — | — | US | claimed |
| WO-2009071831-A1 | REACTION MEDIUM FOR DETECTING AND/OR IDENTIFYING STAPHYLOCCOCUS AUREUS | bioMérieux (FR) | 2009-06-11 | — | — | WO | claimed |
| US-20080193959-A1 | Enzyme Substrates | BURTON MICHAEL | 2008-08-14 | — | — | US | claimed |
| US-7384763-B2 | Method of detecting β-D-ribofuranosidase activity | BURTON MICHAEL | 2008-06-10 | — | — | US | claimed |
| EP-1438424-B1 | ENZYME SUBSTRATES FOR DETECTING BETA-D-RIBOFURANOSIDASE ACTIVITY | BURTON MICHAEL (GB) | 2006-01-18 | — | — | EP | claimed |
| US-20040259181-A1 | detecting beta-D-ribofuranosidase activity using novel chromogenic beta-D-ribofuranoside substrates such as catechol-beta-D-ribofuranoside or 3',4'-dihydroxyflavone-4'-beta-D-dibofuranoside; kits | BURTON MICHAEL (GB) | 2004-12-23 | — | — | US | claimed |
| EP-1438424-A2 | ENZYME SUBSTRATES FOR DETECTING BETA-D-RIBOFURANOSIDASE ACTIVITY | Burton, Michael (GB) | 2004-07-21 | — | — | EP | claimed |
| WO-2003035897-A2 | ENZYME SUBSTRATES FOR DETECTING BETA-D-RIBOFURANOSIDASE ACTIVITY | BURTON MICHAEL (GB) | 2003-05-01 | — | — | WO | claimed |
| US-10443084-B2 | Naphthalene derived chromogenic enzyme substrates | GLYCOSYNTH LIMITED (GB) | 2019-10-15 | — | — | US | disclosed |
| US-20180355403-A1 | NAPHTHALENE DERIVED CHROMOGENIC ENZYME SUBSTRATES | GLYCOSYNTH LIMITED (GB) | 2018-12-13 | — | — | US | disclosed |
| US-9938562-B2 | Naphthalene derived chromogenic enzyme substrates | GLYCOSYNTH LIMITED (GB) | 2018-04-10 | — | — | US | disclosed |
| CN-107446986-A | Culture medium of microorganism and preparation method thereof in a kind of detection blood of human body | 青岛金典生化器材有限公司 | 2017-12-08 | — | — | CN | disclosed |
| EP-1438424-A2 | ENZYME SUBSTRATES FOR DETECTING BETA-D-RIBOFURANOSIDASE ACTIVITY | Burton, Michael (GB) | 2004-07-21 | — | — | EP | disclosed |
| EP-1438423-A1 | ENZYME ACTIVITY INDICATORS | Burton, Michael (GB) | 2004-07-21 | — | — | EP | disclosed |
| WO-2003035897-A2 | ENZYME SUBSTRATES FOR DETECTING BETA-D-RIBOFURANOSIDASE ACTIVITY | BURTON MICHAEL (GB) | 2003-05-01 | — | — | WO | disclosed |
| WO-2003035900-A1 | ENZYME ACTIVITY INDICATORS | BURTON MICHAEL (GB) | 2003-05-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10443084-B2 | Naphthalene derived chromogenic enzyme substrates | MGAM, UGDH, ME1 | SLC28A3 1836/4885HIF1A 2298/4885TYR 47/4885 |
| US-20180355403-A1 | NAPHTHALENE DERIVED CHROMOGENIC ENZYME SUBSTRATES | ME1, XDH, UGDH | SLC28A3 2049/4885HIF1A 1389/4885TYR 55/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.